Clinical Trials Logo

Filter by:
NCT ID: NCT04019808 Completed - Gastric Cancer Clinical Trials

Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population

LEGACY-3
Start date: July 30, 2019
Phase:
Study type: Observational

This study is divided into two parts: Part 1: An interventional study, with a pre-post study design to determinate the grade of knowledge of established GC risk factors. Part 2: An observational study to know impact on prevalence and infection eradication of H. pylori

NCT ID: NCT04015466 Completed - Gastric Cancer Clinical Trials

Advanced GC Multi-omic Characterization in EU and CELAC Populations

LEGACY-2
Start date: June 12, 2019
Phase:
Study type: Observational

Observational study (cohort type) of advanced GC patients that will be recruited prospectively to study biological factors associated with the disease and relevant clinical outcomes.

NCT ID: NCT03957031 Completed - Cancer, Gastric Clinical Trials

Gastric Cancer Risk Factors Associated With EU and CELAC Populations

LEGACY-1
Start date: May 31, 2019
Phase:
Study type: Observational

The study uses a case-control design that examines the differences in types of exposures between cases defined with a pathological confirmation of GC diagnosis, and controls, defined as patients to whom a gastroscopy was indicated and confirmed absent of GC i

NCT ID: NCT03916731 Completed - Clinical trials for End Stage Renal Disease

Evaluation of STARgraft AV for Hemodialysis Access

Start date: April 2, 2019
Phase: N/A
Study type: Interventional

This study is a First-in-Human, single site, prospective, randomized, controlled evaluation of the safety and effectiveness of the Healionics STARgraft AV hemodialysis access graft. The STARgraft has been demonstrated in preclinical studies to have improved resistance to the common failure mode of venous anastomosis stenosis. Performance of the STARgraft AV will be compared against control implants of commercially available standard ePTFE grafts approved for the same use. The study is enrolling patients with End Stage Renal Disease (ESRD) requiring hemodialysis via a prosthetic vascular graft. The study proposes to: 1. Demonstrate improved primary patency of the investigational STARgraft AV compared to the ePTFE controls over a period of 6 months, with extended results to 1 year. 2. Verify safety of the STARgraft AV multilayer construction in extended vascular access use. It is intended to enroll 25 subjects each for the investigational devices and the controls respectively (50 total) with randomized device allocation at subject presentation for implant surgery.

NCT ID: NCT03896789 Completed - Clinical trials for TBI (Traumatic Brain Injury)

Pediatric Guideline Adherence and Outcomes- Argentina

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

Pediatric traumatic brain injury (TBI) is the leading killer of children worldwide but effective treatments for TBI are limited. Although evidenced-based pediatric TBI guidelines exist, adherence to these guidelines is low,leading us to develop a new Pediatric Guideline Adherence and Outcomes (PEGASUS) program to increase TBI guideline adherence. We propose to test the PEGASUS program's ability to improve TBI guideline adherence and outcomes.

NCT ID: NCT03708562 Completed - Clinical trials for Chronic Kidney Diseases

everlinQ Endovascular Access Systems Enhancements (EASE-2) Study

Start date: October 16, 2017
Phase: N/A
Study type: Interventional

Prospective, single-center study to evaluate the everlinQ endoAVF System when used to create an endoAVF in hemodialysis patients. This study aims to investigate expansion of the percutaneous venous access location to the superficial system which may provide additional procedural benefit.

NCT ID: NCT03688893 Completed - Tooth Discoloration Clinical Trials

Efficacy of Laser Application in Dental Bleaching

Start date: September 5, 2015
Phase: N/A
Study type: Interventional

Objective: To establish the efficacy of laser application with chemical treatment in dental bleaching compared to chemical treatment alone. Methods: The investigators conducted a randomized controlled trial (RCT), single blind (evaluator), in 24 patients randomized to laser and chemical intervention (12) or chemical intervention aloe (12). The commercial products used were Whiteness Hp 35% Hydrogen Peroxide and the LASER of DCM Equipments. The trial outcome measures were obtained using the Vita EasyShade Spectrophotometer and the International CIELCh system. To stablish differences before vs. after treatments and between groups, the T test and chi2 tests were applied.

NCT ID: NCT03659552 Completed - Clinical trials for Ventilator-Induced Lung Injury

Percutaneous Temporary Placement of a Transvenous Phrenic Nerve Stimulator for Diaphragm Pacing Using Jugular Access

Start date: May 7, 2018
Phase: N/A
Study type: Interventional

Study conducted to confirm phrenic nerve stimulation using the a transvenous Phrenic Nerve Stimulator in the left jugular vein.

NCT ID: NCT03228381 Completed - Heart Failure Clinical Trials

The BOSS Study: An Acute Evaluation of Anatomical and Geometric Changes Using the Bladder on a Stick System (BOSS)

BOSS
Start date: August 21, 2017
Phase: N/A
Study type: Interventional

The objective of the BOSS Study is to assess acute anatomical and geometric annular and ventricular changes that occur when strategically positioned an external inflatable chambers are applied to the outside of the heart.

NCT ID: NCT02880683 Completed - Cardiac Output, Low Clinical Trials

Cardiac Output Autonomic Stimulation Therapy for Heart Failure (COAST-HF) - Human NeuroCatheter Study

COAST-HF HNrCS
Start date: October 2015
Phase: N/A
Study type: Interventional

A single-center feasibility study in patients undergoing cardiac catheterization, to investigate the acute hemodynamic effects of transvenous cardiac autonomic nerve stimulation.